Page 64 - CIBEREHD2016-ENG

LEAD rESEArCHEr
Clavé Civit, Pere
Fundación Privada Salud del Consorcio Sanitario del Maresme
Carretera de Cirera, S/N 08304 Mataró
(+34) 93 741 77 00 ext 1046 [email protected] group Website
GROUP MEMBERS
Staff members: Álvarez Berdugo, Daniel | Arenas Bailón, Claudia | Ortega Fernández, Omar | Rofes Salsench, Laia
Associated members: Arreola Garcia, Olga Viridiana | Carrion Bolorino, Silvia | Espin Alvarez, Francisco José | Farré Martí, Ricard Lluis | Jiménez Farrerons, Marcelo | Mans Muntwyler, Ester | Martín Ibáñez, María Teresa | Martínez Perea, Vicente | Serra Prat, Mateur | Vergara Esteras, Patrocinio
Main lines of research
• Oropharyngeal and gastroesophageal motility. Pathophysiology, diagnosis and treatment of oropharyngeal and esophageal dysphagia. Pharmacology of swallow response. Oropharyngeal dysphagia and ageing. Neurogenic dysphagia. Brain plasticity.
• Gastrointestinal peptides, control of appetite in ageing and obesity.
• Myenteric mechanisms controlling esophageal motility.
• Intestinal, colonic and anorectal motility. Gastrointestinal pharmacology.
• Neurotransmitters in the colon, small bowel and internal anal sphincter. Purines.NO. H2S. TRPV1. PAR-2.
• Pacemaker function. Interstitial Cells of Cajal.
• Mast cell differentiation and intestinal nerve function: Role of NGF and its implication in the Irritable
Bowel Syndrome (IBS) and postoperative ileus.
• Pathophysiology of intestinal dismotility in IBS and IBD.
• Pathophysiology and treatment with new pharmacological strategies of dismotility in IBS, diverticular
disease, anal fissure.
• Oropharyngeal and gastrointestinal microbiota.
64
PROGRAMMES
P2